United Therapeutics
UTHR
UTHR
504 hedge funds and large institutions have $10.1B invested in United Therapeutics in 2023 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 183 increasing their positions, 165 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
1% less funds holding
Funds holding: 510 → 504 (-6)
18% less capital invested
Capital invested by funds: $12.3B → $10.1B (-$2.19B)
26% less funds holding in top 10
Funds holding in top 10: 23 → 17 (-6)
Holders
504
Holding in Top 10
17
Calls
$40.2M
Puts
$42.6M
Top Buyers
| 1 | +$272M | |
| 2 | +$55M | |
| 3 | +$54.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$46.7M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$37.6M |
Top Sellers
| 1 | -$218M | |
| 2 | -$60.7M | |
| 3 | -$56.1M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$52.6M |
| 5 |
FAM
Fred Alger Management
New York
|
-$41.1M |